Pre-earnings options volume in Aldeyra (ALDX) is normal with calls leading puts 11:1. Implied volatility suggests the market is anticipating a move near 17.5%, or 31c, after results are released. Median move over the past eight quarters is 1.8%.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALDX:
- Aldeyra price target lowered to $9 from $11 at BTIG
- Aldeyra Therapeutics: Promising Pipeline and Strategic Focus Justify Buy Rating Despite FDA Concerns
- Aldeyra Therapeutics: Buy Rating Affirmed Amid Promising Developments and Robust Financial Health
- Aldeyra Therapeutics Receives FDA Complete Response Letter
- Aldeyra options imply 35.3% move in share price post-earnings